These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

89 related items for PubMed ID: 25958051

  • 1. Genetic polymorphism analysis of the drug-metabolizing enzyme CYP2C9 in a Chinese Tibetan population.
    Jin T, Geng T, He N, Shi X, Wang L, Yuan D, Kang L.
    Gene; 2015 Aug 10; 567(2):196-200. PubMed ID: 25958051
    [Abstract] [Full Text] [Related]

  • 2. Genetic analysis of drug metabolizing phase-I enzymes CYP3A4 in Tibetan populations.
    Liu L, Chang Y, Du S, Shi X, Yang H, Kang L, Jin T, Yuan D, He Y.
    J Genet; 2017 Jun 10; 96(2):219-225. PubMed ID: 28674221
    [Abstract] [Full Text] [Related]

  • 3. Polymorphisms and phenotypic analysis of cytochrome P450 2D6 in the Tibetan population.
    Jin TB, Ma LF, Zhang JY, Yuan DY, Sun Q, Zong TY, Geng TT, Cui YL, Kang LL, Chen C.
    Gene; 2013 Sep 15; 527(1):360-5. PubMed ID: 23644254
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Genetic polymorphisms of the drug-metabolizing enzyme CYP2J2 in a Tibetan population.
    Cao P, Zhao Q, Shao Y, Yang H, Jin T, Li B, Li H.
    Medicine (Baltimore); 2018 Oct 15; 97(40):e12579. PubMed ID: 30290621
    [Abstract] [Full Text] [Related]

  • 8. Genotype‑phenotype analysis of CYP2C19 in the Tibetan population and its potential clinical implications in drug therapy.
    Jin T, Zhang X, Geng T, Shi X, Wang L, Yuan D, Kang L.
    Mol Med Rep; 2016 Mar 15; 13(3):2117-23. PubMed ID: 26781306
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Killer cell immunoglobulin-like receptor gene diversity in the Tibetan ethnic minority group of China.
    Zhu BF, Wang HD, Shen CM, Deng YJ, Yang G, Wu QJ, Xu P, Qin HX, Fan SL, Huang P, Deng LB, Lucas R, Wang ZY.
    Hum Immunol; 2010 Nov 15; 71(11):1116-23. PubMed ID: 20650299
    [Abstract] [Full Text] [Related]

  • 11. Cytochrome P450 2C9 (CYP2C9) polymorphisms in Chinese Li population.
    Ding Y, Yang D, Zhou L, He P, Yao J, Xie P, Lin D, Sun D, Sun P, Li Q, Geng T, Jin T.
    Int J Clin Exp Med; 2015 Nov 15; 8(11):21024-33. PubMed ID: 26885033
    [Abstract] [Full Text] [Related]

  • 12. Systematic characterization and comparison of the CYP2C9 variability of the Orang Asli in Malaysia with 12 populations.
    Teh LK, Subramaniam V, Tuan Abdu Aziz TA, Lee LS, Ismail MI, Yu CY, Ang GY, James Johari R, Ismet RI, Sahak NS, Ahmad A, Rahman TA, Nor Ghazali FM, Shaari S, Omar M, Ismail AI, Md Isa K, Salleh H, Salleh MZ.
    Drug Metab Pharmacokinet; 2016 Aug 15; 31(4):304-13. PubMed ID: 27325019
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comprehensive analysis of UGT1A1 genetic polymorphisms in Chinese Tibetan and Han populations.
    Zhang X, Meng X, Wang Y, Yan W, Yang J.
    Biochem Genet; 2012 Dec 15; 50(11-12):967-77. PubMed ID: 22983686
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.